These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31943689)

  • 1. Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohort.
    Chen VL; Singal AG; Tapper EB; Parikh ND
    Liver Int; 2020 Apr; 40(4):947-955. PubMed ID: 31943689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Yekkaluri S; Gopal P; Rich NE; Parikh ND; Murphy CC; Singal AG
    Am J Gastroenterol; 2024 May; 119(5):875-882. PubMed ID: 37975606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
    Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
    JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis.
    Karim MA; Singal AG; Kum HC; Lee YT; Park S; Rich NE; Noureddin M; Yang JD
    Cancer Res Commun; 2023 May; 3(5):874-883. PubMed ID: 37377892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.
    Prapruttam D; Suksai J; Kitiyakara T; Phongkitkarun S
    J Med Assoc Thai; 2014 Nov; 97(11):1199-208. PubMed ID: 25675686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Cano A; Gonzales M; Ransom C; Jaurez E; Carranza O; Quirk L; Morgan T; Gopal P; Patel MS; Lieber S; Louissaint J; Cotter TG; VanWagner LB; Yang JD; Parikh ND; Yopp A; Rich NE; Singal AG
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):295-304.e2. PubMed ID: 37573986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatocellular carcinoma surveillance].
    Costentin C
    Presse Med; 2017 Apr; 46(4):381-385. PubMed ID: 28081946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
    Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
    Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia.
    Hui S; Nguyen A; Le S; Dev A; Bell S
    Intern Med J; 2024 Aug; 54(8):1360-1368. PubMed ID: 38666599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance.
    Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
    J Clin Gastroenterol; 2016 Mar; 50(3):258-65. PubMed ID: 26352107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance.
    Singal AG; Reddy S; Radadiya Aka Patel H; Villarreal D; Khan A; Liu Y; Cerda V; Rich NE; Murphy CC; Tiro JA; Kramer JR; Hernaez R
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2818-2825.e1. PubMed ID: 34902568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.
    Kim HL; An J; Park JA; Park SH; Lim YS; Lee EK
    Hepatology; 2019 Apr; 69(4):1599-1613. PubMed ID: 30365164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
    Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
    J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
    Singal A; Volk ML; Waljee A; Salgia R; Higgins P; Rogers MA; Marrero JA
    Aliment Pharmacol Ther; 2009 Jul; 30(1):37-47. PubMed ID: 19392863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
    Parikh ND; Tayob N; Al-Jarrah T; Kramer J; Melcher J; Smith D; Marquardt P; Liu PH; Tang R; Kanwal F; Singal AG
    JAMA Netw Open; 2022 Jul; 5(7):e2223504. PubMed ID: 35867057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.
    Farhang Zangneh H; Wong WWL; Sander B; Bell CM; Mumtaz K; Kowgier M; van der Meer AJ; Cleary SP; Janssen HLA; Chan KKW; Feld JJ
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1840-1849.e16. PubMed ID: 30580095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.